42442-75-1

Upstream product

• 6090-97-7 (1R,2S,3R,4S,5S,6S)-6-methoxycyclohexane-1,2,3,4,5-pentol 
• 108-24-7 acetic anhydride 
• 551-72-4 inositol 
• 77-78-1 dimethyl sulfate 
• 57090-00-3 2,3-anhydro-allo-inositol 
• 145107-29-5 (+)-Conduritol E epoxide 
• 18391-50-9 (1R)-O¹,O⁵,O⁶-triacetyl-O⁴-methyl-2,3-anhydro-allo-inositol 
• 10284-63-6 pinitol 

Downstream Products

• 1158414-58-4 D-1,2,4,5-tetra-O-acetyl-3-O-methyl-chiro-inositol 
• 1158414-54-0 D-1,2,3,5-tetra-O-acetyl-4-O-methyl-chiro-inositol 

Relevant academic research and scientific papers

MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME

Multibiotic agents are disclosed. The multibiotic agents may contain two or more moieties linked through bonds cleavable in vivo. The bonds cleavable in vivo can be ester bonds, amide bonds, azo bonds, glycosidic bonds, carbonate linkers, or carbamate linkers. The moieties can be alcohol cores, amine cores, and/or acyls. Also disclosed are compositions containing multibiotic agents and methods of using the multibiotic agents.

D-pinitol pro-drug and the method for preparing the same

The present invention provides a D-pinitol prodrug, a manufacturing method thereof, and a pharmaceutical composition comprising the same as an active ingredient. A D-pinitol prodrug of the present invention has a more excellent rate of oral absorption tha

Semi-synthetic analogs of pinitol as potential inhibitors of TNF-α cytokine expression in human neutrophils

Semi-synthetic analogs of pinitol were subjected to screening by determining TNF-α expression in human neutrophils using flowcytometry. Among the tested compounds, three derivatives displayed more than 50% inhibition of TNF-α cytokine secretion in LPS ind